三個皮匠報告
政策庫
new
付費
搜索

2023H1放射性藥物產品及服務營收占比92%-行業數據

2023H1放射性藥物產品及服務營收占比92%
2023H1放射性藥物產品及服務營收占比92%
成長性上，放射性藥物產品及服務和放射源收入增長較快，2017-2022年營收年復合增長率分別為 8.94%、7.69%。
其它 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?14KB 圖片尺寸：1137*849
同報告圖片
 / 37
2023H1放射性藥物產品及服務營收占比92%_第1頁
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
2023H1放射性藥物產品及服務營收占比92%_第2頁
fCDlubTku70gICB8IOavm+WIqeeOhyAgfCDlh4DliKnnjocgIHwKfC0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tfAp8IDIwMTYgICB8IDYwLjAwJSB8IDI1LjAwJSB8CnwgMjAxNyAgIHwgNjIuMDAlIHwgMjUuMDAlIHwKfCAyMDE4ICAgfCA2MS4wMCUgfCAyNC4wMCUgfAp8IDIwMTkgICB8IDU5LjAwJSB8IDIzLjAwJSB8CnwgMjAyMCAgIHwgNTcuMDAlIHwgMjEuMDAlIHwKfCAyMDIxICAgfCA1Ni4wMCUgfCAyMi4wMCUgfAp8IDIwMjIgICB8IDU1LjAwJSB8IDIxLjAwJSB8CnwgMjAyM0gxIHwgNTQuMDAlIHwgMTcuMDAlIHwKCui1hOaWmeadpea6kO+8mldpbmTjgIHlvIDmupDor4HliLjnoJTnqbbmiYA=
2023H1放射性藥物產品及服務營收占比92%_第3頁
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
2023H1放射性藥物產品及服務營收占比92%_第4頁
fCDlubTku70gIHwg5Zub6LS55ZCI6K6hL+aAu+iQpeaUtiAgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDE2IHwgMzYuNSUgICAgICAgICAgICB8CnwgMjAxNyB8IDM4LjAlICAgICAgICAgICAgfAp8IDIwMTggfCAzOS41JSAgICAgICAgICAgIHwKfCAyMDE5IHwgNDEuMCUgICAgICAgICAgICB8CnwgMjAyMCB8IDM5LjAlICAgICAgICAgICAgfAp8IDIwMjEgfCAzNy41JSAgICAgICAgICAgIHwKfCAyMDIyIHwgMzcuMyUgICAgICAgICAgICB8CnwgMjAyM0gxIHwgNDEuNSUgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJpXaW5k44CB5byA5rqQ6K+B5Yi456CU56m25omA
2023H1放射性藥物產品及服務營收占比92%_第5頁
2023H1放射性藥物產品及服務營收占比92%_第6頁
2023H1放射性藥物產品及服務營收占比92%_第7頁
2023H1放射性藥物產品及服務營收占比92%_第8頁
2023H1放射性藥物產品及服務營收占比92%_第9頁
2023H1放射性藥物產品及服務營收占比92%_第10頁
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
2023H1放射性藥物產品及服務營收占比92%_第11頁
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
2023H1放射性藥物產品及服務營收占比92%_第12頁
2023H1放射性藥物產品及服務營收占比92%_第13頁
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
2023H1放射性藥物產品及服務營收占比92%_第14頁
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
2023H1放射性藥物產品及服務營收占比92%_第15頁
5qC55o2u5oKo5o+Q5L6b55qE5L+h5oGv77yM5Lul5LiL5piv5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgojIyMg5pWw5o2u6KGo5qC8Cgp8IOW5tOS7vSB8IOaguOiNr+W4guWcuuinhOaooe+8iOS6v+e+juWFg++8iSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIxIHwgNDAgICAgICAgICAgICAgICAgICAgfAp8IDIwMzAgfCAxMTkuMyAgICAgICAgICAgICAgICB8CgojIyMg6LWE5paZ5p2l5rqQCuaVsOaNruadpea6kO+8muibi+Wjs+eglOeptumZouOAijIwMjMg5qC46I2v6KGM5Lia55m955qu5Lmm44CL77yM5byA5rqQ6K+B5Yi456CU56m25omA
2023H1放射性藥物產品及服務營收占比92%_第16頁
2023H1放射性藥物產品及服務營收占比92%_第17頁
2023H1放射性藥物產品及服務營收占比92%_第18頁
2023H1放射性藥物產品及服務營收占比92%_第19頁
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
2023H1放射性藥物產品及服務營收占比92%_第20頁
2023H1放射性藥物產品及服務營收占比92%_第21頁
2023H1放射性藥物產品及服務營收占比92%_第22頁
2023H1放射性藥物產品及服務營收占比92%_第23頁
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
2023H1放射性藥物產品及服務營收占比92%_第24頁
2023H1放射性藥物產品及服務營收占比92%_第25頁
2023H1放射性藥物產品及服務營收占比92%_第26頁
2023H1放射性藥物產品及服務營收占比92%_第27頁
2023H1放射性藥物產品及服務營收占比92%_第28頁
fCDlubTku70gfCDliY3kupTlpKflrqLmiLfplIDllK7pop3vvIjkuIflhYPvvIkgfCDplIDllK7ljaDmr5QgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18CnwgMjAxOCB8IDkwMDAgICAgICAgICAgICAgICAgICAgICB8IDEwLjAwJSAgIHwKfCAyMDE5IHwgOTUwMCAgICAgICAgICAgICAgICAgICAgIHwgOS41MCUgICAgfAp8IDIwMjAgfCA5MDAwICAgICAgICAgICAgICAgICAgICAgfCA5LjAwJSAgICB8CnwgMjAyMSB8IDg1MDAgICAgICAgICAgICAgICAgICAgICB8IDguNTAlICAgIHwKfCAyMDIyIHwgMTAwMDAgICAgICAgICAgICAgICAgICAgIHwgMTAuMDAlICAgfAoK6LWE5paZ5p2l5rqQ77yaV2luZOOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
2023H1放射性藥物產品及服務營收占比92%_第29頁
2023H1放射性藥物產品及服務營收占比92%_第30頁
2023H1放射性藥物產品及服務營收占比92%_第31頁
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
2023H1放射性藥物產品及服務營收占比92%_第32頁
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
2023H1放射性藥物產品及服務營收占比92%_第33頁
2023H1放射性藥物產品及服務營收占比92%_第34頁
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
2023H1放射性藥物產品及服務營收占比92%_第35頁
2023H1放射性藥物產品及服務營收占比92%_第36頁
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
2023H1放射性藥物產品及服務營收占比92%_第37頁
2023H1放射性藥物產品及服務營收占比92%_第38頁
所屬報告： 原子高科-新三板公司研究報告：背靠中核技術強勁核素藥物龍頭“專精特新”企業-240403（25頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站